Khardin
| Code | Size | Price |
|---|
| TAR-T32393-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Khardin is a bioactive chemical.
CAS:
112143-77-8
Formula:
C12H12ClN5O4S
Molecular Weight:
357.7
Purity:
0.98
SMILES:
VJYIFXVZLXQVHO-UHFFFAOYSA-N
References
1. Gordon KB, Colombel JF, Hardin DS. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. N Engl J Med. 2016 Nov 24;375(21):2102. doi: 10.1056/NEJMc1610828. PubMed PMID: 27959738.
2. Hardin C. Carl Hardin, attorney for the TDA, reports on recent legislative session. J Houston Dist Dent Soc. 1967 Aug;39(8):7-8. PubMed PMID: 5233282.
3. Hardin RE, DeCosky A. A Journal interview with Dr. Rexford E. Hardin. Ohio Dent J. 1977 Nov;51(11):22-6. PubMed PMID: 273826.
4. Hardin J. Regulating cell-cell junctions from A to Z. J Cell Biol. 2016 Apr 25;213(2):151-3. doi: 10.1083/jcb.201604016. PubMed PMID: 27114498; PubMed Central PMCID: PMC4862870.